Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)
Links shared publicly online about this topic.
- 1,845total visits
Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)
fda.gov —
Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)
View full resource at fda.gov
Tags: Disease and Condition, Drug, Children's Health, FDA, Remicade, Enbrel, Humira, Cimzia
Most Recently Shared on August 5, 2009 at 4:45 pm By:
FDA warns of possible connection between drugs for inflammatory disorders and cancer in kids: http://bit.ly/BvQDV
Advertisement
